3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
37
Burkitt Lymphoma
32
Lymphoma
30
Lymphoma, Non-Hodgkin
28
Leukemia, Myeloid, Acute
28
Breast Neoplasms
26
Recurrence
25
Neoplasms
22
Lymphoma, B-Cell
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Myelodysplastic Syndromes
19
Lymphoma, Follicular
18
Triple Negative Breast Neoplasms
17
Melanoma
16
Hodgkin Disease
16
Leukemia
15
Hematologic Neoplasms
15
Neuroblastoma
14
Ovarian Neoplasms
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Mantle-Cell
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Osteosarcoma
9
Neoplasm Metastasis
9
Leukemia, Biphenotypic, Acute
9
Sarcoma
8
Rhabdomyosarcoma
8
Pancreatic Neoplasms
8
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.